drugset / Trial / NCT02534818
Different Fluorescein Sodium Dosage for the Detection of Gastric Intestinal Metaplasia
RandomizedParallel-groupDouble-blindDiagnostic
Summary
The purpose of this study is to assess whether lower fluorescein sodium dosage can perceive the same detection rate per patient and per lesion for the detection of gastric intestinal metaplasia.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluorescein | Diagnostic / imaging agent | 0.02 unknown | — |
| Subject | Fluorescein | Diagnostic / imaging agent | 0.1 unknown | — |